30
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Potassium conservation with amiloride/hydrochlorothiazide (‘Moduret’) in thiazide-induced hypokalaemia in hypertension

, , , , , , , & show all
Pages 120-127 | Received 19 Apr 1982, Published online: 11 Aug 2008

References

  • Aderson J., Godfrey B. E., Hill D. M., Munro-Faure A. D., Sheldon J. A. A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients. Q. J. Med. 1971; 160: 541–5601. Aderson J., Godfrey B. E., Hill D. M., Munro-Faure A. D., Sheldon J. A. A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients. Q. J. Med. 1971; 160: 541–560
  • Antcliff A. C., Beevers D. G., Hamilton M., Harper J. E. Amiloride hydrochloride combined with hydrochlorothiazide in the control of hypertension and plasma potassium levels. Br. J. Clin. Pract. 1972; 26: 413–4172. Antcliff A. C., Beevers D. G., Hamilton M., Harper J. E. Amiloride hydrochloride combined with hydrochlorothiazide in the control of hypertension and plasma potassium levels. Br. J. Clin. Pract. 1972; 26: 413–417
  • Edmonds C. L., Jasani B. M. Total body potassium changes with prolonged diuretic therapy. Am. Heart J. 1973; 85: 569–5713. Edmonds C. L., Jasani B. M. Total body potassium changes with prolonged diuretic therapy. Am. Heart J. 1973; 85: 569–571
  • Edmonds C. J., Wilson G. M. The action of hydroflumethiazide in relation to adrenal steroids and potassium loss. Lancet 1960; 1: 505–5094. Edmonds C. J., Wilson G. M. The action of hydroflumethiazide in relation to adrenal steroids and potassium loss. Lancet 1960; 1: 505–509
  • Landmann-Super R., Struyvenberg A. Initial potassium loss and hypokalemia during chlorthalidone administration in patients with essential hypertension; the influence of dietary sodium restriction. Eur. J. Clin. Invest. 1978; 8: 155–1645. Landmann-Super R., Struyvenberg A. Initial potassium loss and hypokalemia during chlorthalidone administration in patients with essential hypertension; the influence of dietary sodium restriction. Eur. J. Clin. Invest. 1978; 8: 155–164
  • Lauwers P., Conway J., Arbor A. Effect of long term treatment with chlorothiazide on body fluids, serum electrolytes and exchangeable sodium in hypertensive patients. J. Lab. Clin. Med. 1960; 56: 401–4066. Lauwers P., Conway J., Arbor A. Effect of long term treatment with chlorothiazide on body fluids, serum electrolytes and exchangeable sodium in hypertensive patients. J. Lab. Clin. Med. 1960; 56: 401–406
  • Maronde R. F., Milgrom M. E., Dickey J. M. Potassium loss with thiazide therapy. Am. Heart J. 1969; 78: 16–217. Maronde R. F., Milgrom M. E., Dickey J. M. Potassium loss with thiazide therapy. Am. Heart J. 1969; 78: 16–21
  • Morgan T. O. Potassium replacement: supplements or potassium sparing diuretics?. Drugs 1979; 18: 218–2258. Morgan T. O. Potassium replacement: supplements or potassium sparing diuretics?. Drugs 1979; 18: 218–225
  • Multicenter Diuretic Co-operative Study Group. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Arch. Intern. Med. 1981; 141: 482–4869. Multicenter Diuretic Co-operative Study Group. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Arch. Intern. Med. 1981; 141: 482–486
  • Ramsay L. E., Hettiarachci J., Fraser R. E., Morton J. J. Amiloride, spironolactone and potassium chloride in thiazide treated hypertensive patients. Clin. Pharmacol. Ther. 1980; 27: 533–54310. Ramsay L. E., Hettiarachci J., Fraser R. E., Morton J. J. Amiloride, spironolactone and potassium chloride in thiazide treated hypertensive patients. Clin. Pharmacol. Ther. 1980; 27: 533–543
  • Singh B. N., Richmond D. E., Wilson J. D., Simmonds H. A., North J. D. K. Evaluation of MK-870: a new potassium sparing diuretic. Br. Med. J. 1967; 1: 143–14611. Singh B. N., Richmond D. E., Wilson J. D., Simmonds H. A., North J. D. K. Evaluation of MK-870: a new potassium sparing diuretic. Br. Med. J. 1967; 1: 143–146
  • Tarazi R. C., Dustan H. P., Frolich E. D. Long term thiazide therapy in essential hypertension. Circulation 1970; 41: 709–71712. Tarazi R. C., Dustan H. P., Frolich E. D. Long term thiazide therapy in essential hypertension. Circulation 1970; 41: 709–717
  • Van Soeren E. The antihypertensive and biochemical effects of amiloride/hydro-chlorothiazide (‘Moduret’) versus chlorthalidone. J. Int. Med. Res. 1980; 8: 132–13513. Van Soeren E. The antihypertensive and biochemical effects of amiloride/hydro-chlorothiazide (‘Moduret’) versus chlorthalidone. J. Int. Med. Res. 1980; 8: 132–135
  • Wilson J. D., Richmond D. E., Simmonds H. A., North J. D. K. MK-870: a new potassium sparing diuretic. N.Z. Med. J. 1966; 65: 505–50914. Wilson J. D., Richmond D. E., Simmonds H. A., North J. D. K. MK-870: a new potassium sparing diuretic. N.Z. Med. J. 1966; 65: 505–509

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.